Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes

NCT06069206 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Bloodstream Infection
Sepsis Bacterial
MRSA Bacteremia
Vancomycin

Interventions

OTHER: T2Bacteria® Panel (direct-from-blood testing)
OTHER: Usual Care

Sponsor

Vanderbilt University Medical Center